19.09.2023 Talanx Aktiengesellschaft  DE000TLX1005

EQS-Adhoc: Talanx Aktiengesellschaft: Capital increase of Talanx AG successfully completed


EQS-Ad-hoc: Talanx Aktiengesellschaft / Key word(s): Capital Increase
Talanx Aktiengesellschaft: Capital increase of Talanx AG successfully completed

19-Sep-2023 / 23:30 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.





Publication of inside information pursuant to Article 17 (1) of Regulation (EU) No. 596/2014 on Market Abuse (Market Abuse Regulation - MAR)


Capital increase of Talanx AG successfully completed

Talanx AG has successfully completed the execution of the announced capital increase. 4,878,048 new shares from authorized capital were placed with institutional investors at a price of EUR 61.50 per share, excluding pre-emptive subscription rights for existing shareholders, through partial utilization of authorized capital in an accelerated bookbuilding process. The new shares will be issued with profit participation rights as of 1 January 2023. The company will receive gross proceeds of approx. EUR 300 million from this capital increase.

The 1,626,016 Talanx shares held by HDI V.a.G. that were also offered for sale were placed at the same conditions, so that the latter's share in the share capital of Talanx AG is reduced to 76.7%.

The free float of Talanx AG will increase to 23.3% after completion of the transaction.


Important notice

This announcement may not be published, distributed or transmitted, directly or indirectly, in the United States of America (including its territories and possessions), Canada, Japan or Australia or any other jurisdiction where such announcement could be unlawful. The distribution of this announcement may be restricted by law in certain jurisdictions and persons who are in possession of this document or other information referred to herein should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement does not constitute an offer of, or a solicitation of an offer to purchase, securities of Talanx Aktiengesellschaft or of any of its subsidiaries in the United States of America, Germany or any other jurisdiction. Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, an offer in any jurisdiction. The securities offered will not be and have not been registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements under the Securities Act.

In the United Kingdom, this announcement is only directed at persons (i) who are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order"), (ii) are falling within Article 49(2)(a) to (d) of the Order (high net worth companies, unincorporated associations, etc.) or (iii) to whom it may otherwise be lawfully communicated (all such persons together being referred to as "Relevant Persons")). This document must not be acted on, or relied upon, by persons who are not Relevant Persons. Any investment or investment activity to which this document relates is available only to Relevant Persons and will be engaged in only with Relevant Persons.

In member states of the European Economic Area and the United Kingdom the placement of securities described in this announcement (the "Placement") is directed exclusively at persons who are "qualified investors" within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 (Prospectus Regulation).

No action has been taken that would permit an offering or an acquisition of the securities or a distribution of this announcement in any jurisdiction where such action would be unlawful. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.

This announcement does not constitute a recommendation concerning the Placement. Investors should consult a professional advisor as to the suitability of the Placement for the person concerned.

This release may contain forward looking statements, estimates, opinions and projections with respect to anticipated future performance of Talanx Aktiengesellschaft ("forward-looking statements"). These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes," "estimates," "anticipates," "expects," "intends," "may," "will" or "should" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. Forward-looking statements are based on the current views, expectations and assumptions of the management of Talanx Aktiengesellschaft and involve significant known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Forward-looking statements should not be read as guarantees of future performance or results and will not necessarily be accurate indications of whether or not such results will be achieved. Any forward-looking statements included herein only speak as at the date of this release. We undertake no obligation, and do not expect to publicly update, or publicly revise, any of the information, forward-looking statements or the conclusions contained herein or to reflect new events or circumstances or to correct any inaccuracies which may become apparent subsequent to the date hereof, whether as a result of new information, future events or otherwise. We accept no liability whatsoever in respect of the achievement of such forward-looking statements and assumptions.


Information to Distributors

Pursuant to EU product governance requirements, the shares have been subject to a product approval process, under which each distributor has determined that such shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II. Any distributor subsequently offering the shares is responsible for undertaking its own target market assessment in respect of the shares and determining appropriate distribution channels.

Bernd Sablowsky
Head of Investor Relations
HDI-Platz 1
30659 Hannover
Tel: +49 511 3747 2231

End of Inside Information

19-Sep-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language: English
Company: Talanx Aktiengesellschaft
HDI-Platz 1
30659 Hannover
Phone: +49 511 3747 2227
Fax: +49 511 3747 2286
E-mail: [email protected]
Internet: www.talanx.com
ISIN: DE000TLX1005
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Hanover; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange
EQS News ID: 1729875

End of Announcement EQS News Service

1729875  19-Sep-2023 CET/CEST


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 33.060,00 34.885,00 39.494,00 41.109,00 45.507,00 53.431,00 0,00
EBITDA1,2 1.870,00 2.032,00 2.430,00 1.671,00 2.454,00 3.372,00 0,00
EBITDA-Marge3 5,66 5,82 6,15 4,06 5,39 6,31
EBIT1,4 1.870,00 2.032,00 2.430,00 1.671,00 2.454,00 3.372,00 0,00
EBIT-Marge5 5,66 5,82 6,15 4,06 5,39 6,31 0,00
Jahresüberschuss1 1.269,00 1.359,00 1.671,00 1.196,00 1.730,00 2.461,00 1.570,00
Netto-Marge6 3,84 3,90 4,23 2,91 3,80 4,61 0,00
Cashflow1,7 5.006,00 3.823,00 6.972,00 6.319,00 10.049,00 5.966,00 0,00
Ergebnis je Aktie8 2,66 2,78 3,65 2,66 4,00 4,63 6,00
Dividende8 1,40 1,45 1,50 1,50 1,60 2,00 1,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2022 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

WKN Kurs in € Einschätzung Börsenwert in Mio. €
TLX100 64,550 Halten 16.668,68
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
10,09 10,70 0,97 18,90
3,39 2,79 0,31 4,94
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
2,00 2,15 3,33 07.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
15.05.2024 14.08.2024 13.11.2023 21.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-2,14% 7,12% -0,15% 42,94%
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Talanx Aktiengesellschaft  ISIN: DE000TLX1005 können Sie bei EQS abrufen

Versicherungen , TLX100 , TLX , XETR:TLX